Acute effects of partial positive allosteric Gabaa receptor modulation by GT-002 on psychophysiological and cognitive measures
Protocol for the Totems phase II trial targeting cognitive impairment associated with schizophrenia
Bibliographic Data
| ID | 15517794 |
|---|---|
| Authors | Thomas Hartwig Siebner (Glostrup Hospital, corresponding author), Karen Sandø Ambrosen (Glostrup Hospital), Cecilie Koldbæk Lemvigh (Glostrup Hospital), Christine Natasha Ryan (Södertälje Sjukhus), Mikkel Erlang Sørensen (Glostrup Hospital), María Hernández-Lorca (Glostrup Hospital), Birte Yding Glenthøj (University of Copenhagen), Kit Melissa Larsen (0000-0002-4204-1607, Amager Hospital), Michael-Robin Witt (Södertälje Sjukhus), Bob Oranje (0000-0001-8408-4800, Glostrup Hospital), Bjørn Hylsebeck Ebdrup (University of Copenhagen) |
| Year | 2025 |
| Volume | 16 |
| Pages | 1656792-1656792 |
| Publication date | 2025-11-25 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Psychiatry (JOURNAL) |
| Journal identifiers | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Publisher | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2025.1656792 |
| PMID | 41473758 |
| OpenAlex | W7115198526 |
| Language | EN |
| References cited | 105 |
EU CT number 2024-519389-28-00
Allosteric modulator · Allosteric regulation · Benzodiazepine · Cognition · Cognitive impairment · GABAA receptor · Receptor · Schizophrenia (object-oriented programming · Neural dynamics and brain function · Neuroscience and Neuropharmacology Research · Tryptophan and brain disorders
| Highly cited | No |
|---|